Skip to content
Avro Life Science logo

Avro Life Science

Avro Life Science is a YC Winter 2018 (W18) company. Based in Waterloo, ON, Canada. Team of 8.

  • Biotech
  • Drug Delivery

About Avro Life Science

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Avro Life Science develops topical drug delivery platforms that enable drug molecules to pass passively through the skin, a route that conventional formulations cannot achieve. Its technology targets medical dermatology, replacing systemic drug delivery methods with transdermal alternatives for generic and novel therapeutics. The company is at the clinical stage, advancing a pipeline of drug candidates built on its proprietary platform.

Go-to-market

Avro Life Science advances its own clinical-stage pipeline of drug candidates, positioning its platform technology toward pharmaceutical partners and the broader medical dermatology market.

From the Y Combinator listing

How Avro Life Science describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Skin patches for generic drug delivery.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
Waterloo, ON, Canada
Team size
8
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works